Hand-10 Questionnaire in Children With Unilateral Cerebral Palsy

NCT06887530 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2025-06-25

No results posted yet for this study

Summary

A Turkish version of the Hand-10 (unabbreviated) questionnaire has been developed, but its validity and reliability in cerebral palsy has not yet been proven. In particular, questioning daily life activities with visual content can make a significant contribution to evaluating hand functions and independence. Therefore, the aim of this planned study was to investigate the validity and reliability of the Hand-10 questionnaire in cerebral palsy.

Conditions

  • Cerebral Palsy (CP)
  • Hand Functions

Interventions

OTHER

Hand-10 questionnaire and ABILHAND-kids questionnaire

Children and their parents included in the study will be informed about the purpose of the study and the evaluations to be made and will be asked to sign a written consent form. The questions in the data collection form will be asked to individuals in a face-to-face interview. The manual skills classification system, Hand-10 questionnaire and ABILHAND-kids questionnaire will be used. While validating the Hand10 questionnaire in children with cerebral palsy, it was planned to use the ABILHAND-kids scale, which has been previously validated for reliability and validity in cerebral palsy. It was also planned to use the hand function classification system in the evaluations. The Hand-10 questionnaire will be filled out by the child himself. The ABILHAND-kids questionnaire will be filled out by the parent. An expert will record the manuel ability system according to the hand skills.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Rabia ZORLULAR · Gazi University

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-21
Primary Completion
2025-05-20
Completion
2025-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06887530 on ClinicalTrials.gov